Clinical cases of treatment of hepatocellular carcinoma

Abstract

The article presents the clinical cases of sorafenib treatment of hepatocellular carcinoma. The experience of the Russian oncologistsdoes not only confirm the results of the international clinical research, but also demonstrates the possibility of prolonged administration of the drug for more than 3-4 years against a backdrop of high efficiency and controlled security profile.

Keywords

• hepatocellular carcinoma
• primary liver cancer
• targeted therapy
• sorafenib